...
首页> 外文期刊>Biomaterials >Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy
【24h】

Biocompatible and biodegradable zeolitic imidazolate framework/polydopamine nanocarriers for dual stimulus triggered tumor thermo-chemotherapy

机译:用于双刺激的生物相容性和可生物降解的沸石咪唑酯骨架/聚二胺纳米载体触发肿瘤热化疗

获取原文
获取原文并翻译 | 示例

摘要

Zeolitic imidazolate frameworks (ZIFs) have attracted great interest as pH-sensitive drug carrier because of high drug loading and intrinsic biodegradability. In this work, a biocompatible NIR and pH-responsive drug delivery nanoplatform based on ZIFs (PDA-PCM@ZIF-8/DOX) is synthesized for in vivo cancer therapy. The biocompatibility of ZIFs is greatly improved by polydopamine (PDA) modifying and proved by cytotoxicity and in vivo acute toxicity evaluation. The degradability is also regulated in an appropriate rate. Due to mild reaction condition of ZIFs, the synthesis and drug loading is achieved in one pot with high loading (37.86%) and encapsulation rate (78.76%). Meanwhile, PDA acts as a photothermal transfer agent to trigger thermal response switch of phase change materials for NIR controlled drug release. Under the dual stimulus of NIR and acid environment, the drug release is as high as 78%, while only 21% is released without stimulus, showing a remarkable effect of control release. In vivo anti-tumor experiments demonstrate the high tumor inhibition rate of photothermal-chemotherapy group with a significant synergistic effect. The biocompatible and biodegradable drug delivery platform based on ZIFs has shown great promise for future clinic cancer therapy. (C) 2018 Elsevier Ltd. All rights reserved.
机译:由于药物负荷高,生物化性高,Zeolital Imidazolate框架(Zifs)吸引了对pH敏感药物载体的极大兴趣。在这项工作中,基于Zifs(PDA-PCM @ ZIF-8 / DOX)的生物相容性NIR和pH-响应药物递送纳米片以体内癌症治疗合成。通过聚德胺(PDA)改善和通过细胞毒性和体内急性毒性评估得到大大改善Zifs的生物相容性。降解性也以适当的速率调节。由于Zifs的温和反应条件,合成和药物载荷在一个高负载(37.86%)和包封率(78.76%)的一个罐中实现。同时,PDA充当光热转移剂,以触发用于NIR控制药物释放的相变材料的热响应开关。在NIR和酸性环境的双重刺激下,药物释放高达78%,而在没有刺激的情况下释放只有21%,显示出对照释放的显着作用。体内抗肿瘤实验证明了光热化疗基团的高肿瘤抑制率,具有显着的协同作用。基于Zifs的生物相容性和可生物降解的药物递送平台对未来的临床癌症治疗具有很大的承诺。 (c)2018年elestvier有限公司保留所有权利。

著录项

  • 来源
    《Biomaterials 》 |2018年第2018期| 共12页
  • 作者单位

    Chinese Acad Sci Tech Inst Phys &

    Chem Lab Controllable Preparat &

    Applicat Nanomat Key Lab;

    China Med Univ Dept Radiol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Radiol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    Chinese Acad Sci Tech Inst Phys &

    Chem Lab Controllable Preparat &

    Applicat Nanomat Key Lab;

    Chinese Acad Sci Tech Inst Phys &

    Chem Lab Controllable Preparat &

    Applicat Nanomat Key Lab;

    Chinese Acad Sci Tech Inst Phys &

    Chem Lab Controllable Preparat &

    Applicat Nanomat Key Lab;

    Chinese Acad Sci Tech Inst Phys &

    Chem Lab Controllable Preparat &

    Applicat Nanomat Key Lab;

    Chinese Acad Sci Tech Inst Phys &

    Chem Lab Controllable Preparat &

    Applicat Nanomat Key Lab;

    China Med Univ Dept Radiol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    China Med Univ Dept Radiol Hosp 1 Shenyang 110001 Liaoning Peoples R China;

    Chinese Acad Sci Tech Inst Phys &

    Chem Lab Controllable Preparat &

    Applicat Nanomat Key Lab;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物医学工程 ;
  • 关键词

    Zeolitic imidazolate framework; Biodegradability; Drug release; Photothermal therapy; Chemotherapy;

    机译:沸石咪唑酯骨架;生物降解性;药物释放;光热疗法;化疗;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号